|
⚲
|
| Keyboard |
| Fairmount Healthcare Fund II GP LLC | |
|---|---|
| Firm | |
| Address | 200 Barr Harbor Drive Suite 400 West Conshohocken, PA 19428 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Fairmount Healthcare Feeder Fund II LP | 021-334107 | Executive Officer | 944.9 M | ||
| Fairmount Healthcare Fund II LP | 021-334111 | Executive Officer | 598.3 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-10-23 | Buy | 454,545 | $22.00 | 9,999,990 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-06-10 | Option exercise | 12,500 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-06-10 | Option exercise | 12,500 | $12.31 | 153,875 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Option exercise | 1,600 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-06-09 | Option exercise | 1,600 | $7.80 | 12,480 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-09-13 | Buy | 1,600,000 | $18.75 | 30,000,000 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-03-28 | Other | 5,859 | ||
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-03-28 | Other | 5,859 | ||
|
Miragen Therapeutics Inc VRDN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2024-03-28 | Other | 21,999 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2024-03-28 | Other | 21,999 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-01-22 | Buy | 476,190 | $21.00 | 9,999,990 |
|
Miragen Therapeutics Inc VRDN
Series B Non-Voting Convertible Preferred Stock · derivative
|
2023-10-30 | Grant | 48,463 | $825.37 | 39,999,906 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-08-17 | Buy | 425,531 | $23.50 | 9,999,978 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2021-09-21 | Buy | 909,000 | $11.00 | 9,999,000 |
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-30 | Buy | 28,843 | $465.96 | 13,439,684 |
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-30 | Buy | 5,494 | $465.96 | 2,559,984 |
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-27 | Other | 16,505 | ||
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-27 | Other | 82,349 | ||
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2020-10-27 | Other | 438,502 | ||
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2020-10-27 | Other | 87,891 |